Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Melby

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Infection and Immunity|March 1, 1994
Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasisP C Melby, F J Andrade-Narvaez, B J Darnell, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasisH M Al-Abdely, J R Graybill, R Bocanegra, et al.
The Journal of Experimental Medicine|July 19, 2000
CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammationN Sato, S K Ahuja, M Quinones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infectionS S Ahuja, R L Reddick, N Sato, et al.
Infection and Immunity|September 19, 2000
Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression libraryP C Melby, G B Ogden, H A Flores, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 1999
Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient miceN Sato, W A Kuziel, P C Melby, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Infection and Immunity|March 1, 1994
Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasisP C Melby, F J Andrade-Narvaez, B J Darnell, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasisH M Al-Abdely, J R Graybill, R Bocanegra, et al.
The Journal of Experimental Medicine|July 19, 2000
CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammationN Sato, S K Ahuja, M Quinones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infectionS S Ahuja, R L Reddick, N Sato, et al.
Infection and Immunity|September 19, 2000
Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression libraryP C Melby, G B Ogden, H A Flores, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 1999
Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient miceN Sato, W A Kuziel, P C Melby, et al.
Pageof 4